Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoFurther, Moderna confirmed it's in discussions with the U.S. government to move forward with its...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
Good Morning America via Yahoo News· 4 days agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 4 days agoA combined flu and Covid vaccine from Moderna provokes a higher immune response than separate single...
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 11 hours agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination < ...
Moderna says its combination COVID and flu vaccine tested better than separate shots
CBS News· 4 days agoModerna announced Monday that its combination COVID and flu vaccine showed positive results in a...
Moderna (NASDAQ:MRNA) Stock Price Down 2.2% on Insider Selling
ETF DAILY NEWS· 15 hours agoShares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) traded down 2.2% during mid-day trading on Wednesday following insider selling activity. 392,597 shares changed hands ...
Moderna Announces Good Results From Trial of Combo COVID/FluVaccine | Fox 11 Tri Cities Fox 41...
FOX 11/41 Yakima· 4 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 20 hours agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance via AOL· 3 days ago(List price for Moderna's COVID vaccine: $110.) So while the Moderna vaccines "are good for public...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 4 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...